Dr. Richard Isaacson’s groundbreaking research was featured on CNN’s Anderson Cooper 360°, where Chief Medical Correspondent Dr. Sanjay Gupta highlighted a study demonstrating how blood biomarkers can be used not only to assess Alzheimer’s risk, but also to monitor how personalized lifestyle interventions may improve brain health over time.

During the segment, Dr. Gupta explained how Dr. Isaacson’s precision prevention program uses more than 125 biomarkers to create individualized strategies for reducing Alzheimer’s risk. Drawing on his own experience as a participant in the study, Dr. Gupta described recommendations from Dr. Isaacson’s team—including continuous glucose monitoring, weighted walking, targeted nutritional supplements, and barefoot walking or toe spacers—to improve metabolic health, build lean muscle, and support healthy brain aging.

The segment also explored Dr. Isaacson’s vision for the future of Alzheimer’s prevention through at-home blood biomarker testing, allowing individuals to track changes over time and better understand how lifestyle modifications may influence their long-term cognitive health.

Watch the full CNN Anderson Cooper 360° segment to learn how precision medicine and blood biomarker testing are helping transform the future of Alzheimer’s prevention.